...current tranche included Oxford Bioscience Partners; HealthCare Ventures; GeneChem; GIMV; Hambrecht & Quist Capital Management; Still River Fund...

...Capital-Technology Ventures; Hambrecht & Quist; GIMV; Genechem; China Development Industrial Bank; CDIB BioScience Ventures; Yasuda; Still River Fund...

...Hambrecht & Quist; GIMV; Genechem; China Development Industrial Bank; CDIB BioScience Ventures; Yasuda.; HealthCare Ventures; Still River Fund...

...DNA, raised $17 million in a private round. Investors included HealthCare Ventures; CB Health Ventures; Still River Fund...